1.225
price down icon0.41%   -0.005
pre-market  Vorhandelsmarkt:  1.20   -0.025   -2.04%
loading

Nuwellis Inc Aktie (NUWE) Neueste Nachrichten

pulisher
Apr 09, 2026

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services - Bitget

Apr 09, 2026
pulisher
Apr 09, 2026

Nuwellis retains CORE IR for investor relations services By Investing.com - Investing.com

Apr 09, 2026
pulisher
Apr 09, 2026

Nuwellis brings in CORE IR to sharpen investor outreach and social media - Stock Titan

Apr 09, 2026
pulisher
Apr 07, 2026

Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK

Apr 07, 2026
pulisher
Apr 07, 2026

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory - Bitget

Apr 07, 2026
pulisher
Apr 07, 2026

Can Nuwellis Inc stock double in the next yearQuarterly Profit Review & Community Consensus Trade Alerts - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 07, 2026

Nuwellis (NUWE) Expands Commercial Reach in South Texas - GuruFocus

Apr 07, 2026
pulisher
Apr 07, 2026

Nuwellis Inc Strengthens Commercial Infrastructure with New South Texas Territory - marketscreener.com

Apr 07, 2026
pulisher
Apr 07, 2026

South Texas hospitals get dedicated Nuwellis team for fluid care - Stock Titan

Apr 07, 2026
pulisher
Apr 04, 2026

Nuwellis signs letter of intent to acquire Rendiatech - MSN

Apr 04, 2026
pulisher
Apr 02, 2026

Nuwellis (NASDAQ: NUWE) outlines 2026 virtual meeting, director elections and auditor ratification - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Nuwellis, Inc. Form 8-K/A Filing Details, Company Information, and SEC Compliance Disclosures - Minichart

Apr 02, 2026
pulisher
Apr 01, 2026

Former Nuwellis (NASDAQ: NUWE) directors submit response letters - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Nuwellis reports pediatric segment reaches 50% of U.S. revenue By Investing.com - Investing.com South Africa

Apr 01, 2026
pulisher
Mar 31, 2026

Nuwellis Pediatric Business Continues Growth Momentum - Intellectia AI

Mar 31, 2026
pulisher
Mar 31, 2026

In fiscal year 2025, the pediatric business segment under Nuwellis, Inc. demonstrated strong growth, with its sales revenue in the U.S. market approaching 50% of the company's total domestic revenue. - Bitget

Mar 31, 2026
pulisher
Mar 31, 2026

Nuwellis reports pediatric segment reaches 50% of U.S. revenue - Investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone - Bitget

Mar 31, 2026
pulisher
Mar 31, 2026

Nuwellis Pediatric Category Achieves Approximately 50% Of Total U.S. Revenue In 2025, Marking Growth Milestone - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

Half of Nuwellis U.S. revenue now comes from pediatric care - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Macro Review: Is Nuwellis Inc forming a breakout pattern2026 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 28, 2026

Nuwellis (LTS:0HQX) PE Ratio : N/A (As of Mar. 28, 2026) - GuruFocus

Mar 28, 2026
pulisher
Mar 28, 2026

Nuwellis, Inc. Files Form 8-K Reporting Company Information and SEC Compliance Details - Minichart

Mar 28, 2026
pulisher
Mar 27, 2026

Nuwellis announces resignations of two board members and reduces board size - Investing.com UK

Mar 27, 2026
pulisher
Mar 27, 2026

Nuwellis Board Directors Resign Amid Governance Dispute - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

[8-K] Nuwellis, Inc. Reports Material Event - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Nuwellis Inc (NUWE) Stock Price & 30 Year Financial Data - GuruFocus

Mar 27, 2026
pulisher
Mar 25, 2026

Risk Report: What is Nuwellis Incs 5 year growth outlook2026 Setups & Long-Term Capital Growth Ideas - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 19, 2026

Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn

Mar 19, 2026
pulisher
Mar 18, 2026

Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis Completes Acquisition of Rendiatech - Bitget

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Nuwellis completes acquisition of Rendiatech - marketscreener.com

Mar 17, 2026
pulisher
Mar 13, 2026

Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN

Mar 13, 2026
pulisher
Mar 13, 2026

Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com

Mar 13, 2026
ZBH ZBH
$94.20
price down icon 2.40%
STE STE
$221.50
price down icon 1.48%
$61.54
price down icon 2.24%
PHG PHG
$29.09
price up icon 0.00%
$73.51
price down icon 1.55%
EW EW
$78.20
price up icon 0.00%
Kapitalisierung:     |  Volumen (24h):